PAPER Monson NL, Ireland SJ, Ligocki AJ, Chen D, Rounds WH, Li M, Huebinger RM, Munro Cullum C, Greenberg BM, Stowe AM, Zhang R
SEARCH RESULTS
331159 RESULTS
PAPER Molinuevo JL, Casado-Naranjo I
Clinical Evolution of Alzheimer's Disease: Is the Age of the Patient a Decisive Factor? Results of the INFLUENCE Study.
J Alzheimers Dis. 2013 Oct 22; PubMed: 24150103PAPER Xu S, Liu G, Bao X, Wu J, Li S, Zheng B, Anwyl R, Wang Q
Rosiglitazone Prevents Amyloid-β Oligomer-Induced Impairment of Synapse Formation and Plasticity via Increasing Dendrite and Spine Mitochondrial Number.
J Alzheimers Dis. 2013 Oct 22; PubMed: 24150104PAPER Brugnolo A, Morbelli S, Arnaldi D, De Carli F, Accardo J, Bossert I, Dessi B, Famà F, Ferrara M, Girtler N, Picco A, Rodriguez G, Sambuceti G, Nobili F
Metabolic Correlates of Rey Auditory Verbal Learning Test in Elderly Subjects with Memory Complaints.
J Alzheimers Dis. 2013 Oct 22; PubMed: 24150105PAPER Nafar F, Mearow KM
Coconut oil attenuates the effects of amyloid-β on cortical neurons in vitro.
J Alzheimers Dis. 2014;39(2):233-7. PubMed: 24150106PAPER Asti A, Gioglio L
Can a Bacterial Endotoxin be a Key Factor in the Kinetics of Amyloid Fibril Formation?
J Alzheimers Dis. 2013 Oct 22; PubMed: 24150108PAPER Mandal PK, Ritchie K, Fodale V
Anesthetics and its Impact on the Brain and Alzheimer's Disease.
J Alzheimers Dis. 2013 Oct 22; PubMed: 24150107PAPER Yu D, Lapointe NE, Guzman E, Pessino V, Wilson L, Feinstein SC, Valentine MT
Tau Proteins Harboring Neurodegeneration-Linked Mutations Impair Kinesin Translocation in vitro.
J Alzheimers Dis. 2013 Oct 22; PubMed: 24150109PAPER Marchese M, Cowan D, Head E, Ma D, Karimi K, Ashthorpe V, Kapadia M, Zhao H, Davis P, Sakic B
Autoimmune Manifestations in the 3xTg-AD Model of Alzheimer's Disease.
J Alzheimers Dis. 2013 Oct 22; PubMed: 24150111PAPER Lu PH, Lee GJ, Shapira J, Jimenez E, Mather MJ, Thompson PM, Bartzokis G, Mendez MF
Regional Differences in White Matter Breakdown Between Frontotemporal Dementia and Early-Onset Alzheimer's Disease.
J Alzheimers Dis. 2013 Oct 22; PubMed: 24150110PAPER Weisová P, Alvarez SP, Kilbride SM, Anilkumar U, Baumann B, Jordán J, Bernas T, Huber HJ, Düssmann H, Prehn JH
Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability.
Transl Psychiatry. 2013;3:e317. PubMed: 24150226PAPER Delaby C, Gabelle A, Meynier P, Loubiere V, Vialaret J, Tiers L, Ducos J, Hirtz C, Lehmann S
Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid.
Clin Chem Lab Med. 2013 Oct 23;:1-7. PubMed: 24150208PAPER Franchi C, Arosio F, Djade CD, Salvini Porro G, Nobili A
Caregivers' perceptions of the therapeutic benefits of drug treatments for dementia.
Aging Clin Exp Res. 2013 Dec;25(6):677-83. PubMed: 24150573PAPER Veerappan CS, Sleiman S, Coppola G
Epigenetics of Alzheimer's disease and frontotemporal dementia.
Neurotherapeutics. 2013 Oct;10(4):709-21. PubMed: 24150812PAPER Morra LF, Donovick PJ
Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review.
Int J Geriatr Psychiatry. 2013 Oct 21; PubMed: 24150834Current Filters
No filters selected